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Background: Most reports mention isolated tubular dysfunction in active lupus nephritis and, hence, the present
study was designed to investigate varied functional defects in Indian patients with stable lupus nephritis.
Methods: Twenty patients with lupus nephritis were evaluated for evidence of renal tubular functional
abnormalities. Disease activity was studied using the Systemic Lupus Erythematosus Disease Activity Index
(SLEDAI). Renal histology was available for 12 patients, including six with WHO class IV disease and three
each with class III and class V disease. Analysis of activity and chronicity indices as well as severity of tubulo-
interstitial involvement was also done on these biopsy specimens. Estimation of fractional excretion (FE) of
beta-2 microglobulin (`2+g), 24-hour urinary excretion of alkaline phosphatase (ALP), leucine aminopeptidase
(LAP) and gamma-glutamyltransferase (GGT), as well as the short ammonium chloride (NH4Cl) test, were
performed in all patients. Ten healthy volunteers served as controls.
Results: The mean creatinine clearance (Ccr) was 58.9 ( 19.1 mL/min (range, 24.5–104.3 mL/min). Serum
`2+g and FE-`2+g were elevated in all patients (mean, 5.5 ( 1.4 mg/L and 1.6 ( 0.9%, respectively). Urinary
ALP excretion was elevated in 65% of patients, with a mean of 6.88 ( 5.08 +mol/L/min, and urinary GGT
excretion was elevated in 50% of patients, with a mean of 59.43 ( 33.70 +mol/L/min. There was no significant
correlation of serum `2+g, FE-`2+g, and urinary ALP levels with Ccr or severity of proteinuria. Urinary GGT
levels were increased proportionately to the decrease in Ccr. Only 20% of patients were unable to acidify their
urine (pH < 5.3); the minimum urinary pH was higher in the lupus nephritis patients compared to controls
(5.17 ( 0.58 vs 4.65 ( 0.26; p < 0.05). The mean baseline and peak titratable acidity were not significantly
lower in lupus nephritis patients. There was significant correlation of all renal functional abnormalities with
the severity of SLEDAI and tubulo-interstitial involvement.
Conclusions: Both proximal and distal tubular functional abnormalities were seen in patients with lupus nephritis
and can co-exist. FE-`2+g is the most sensitive indicator of proximal tubal dysfunction. Assessment of urinary
enzymes may give an early indication of tubular dysfunction. Disease activity and severity of tubulo-interstitial
involvement influence these abnormalities. [Hong Kong J Nephrol 2003;5(2):90–7]
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INTRODUCTION
Tubulo-interstitial involvement has been described in
up to 70% of biopsies from lupus patients, usually in
association with glomerular lesions [1–4]. Isolated
tubulo-interstitial lesions without glomerular
involvement have been described only rarely [5]. A
variety of changes in tubular function have been
described in lupus nephrit is .  These include
abnormalities of proximal tubular dysfunction such as
increased fractional excretion (FE) of beta-2
microglobulin (`2+g) and dimercaptosuccinic acid
(DMSA) [6,7], as well as distal tubular dysfunction
including submaximal concentrating ability and
acidification [8,9]. In addition, distal renal tubular
acidosis and hyporeninemic hypoaldosteronism [10,
11], normotensive hyperreninemia [12], and reduced
potassium excretion [13] have been reported in patients
with systemic lupus erythematosus (SLE).
Most authors studied individual tubular function.
FE-`2+g and DMSA were prospectively studied by ter
Borg et al in eight patients during lupus exacerbation
[9]. Yeung et al evaluated FE-`2+g, maximal
concentrating ability and maximal urinary acidification
in 20 patients [6]. Feng studied concentrating ability
and performed the acid load test in 37 lupus nephritis
patients [14]. Kozeny et al evaluated distal tubular
acidification in detail by ammonium chloride loading
and the sodium sulfate test in 30 lupus patients [10].
Values of urinary enzymes for evaluation of tubular
function were also studied by Delektorskaya et al in 31
patients [15] and Rovensky et al in 54 patients [16]
with lupus nephritis. Nevertheless, there is no study
that systematically evaluated the various components
of tubular function at the same time in lupus nephritis
patients. The present study aimed to prospectively
evaluate various tubular functions including urinary
enzyme excretion in a cohort of Indian patients with
stable lupus nephritis.
PATIENTS AND METHODS
Subjects
Twenty patients who satisfied the American College
of Rheumatology criteria for the diagnosis of SLE
and had evidence of renal disease were studied [17].
Renal involvement was defined by the presence of
2+ proteinuria on semiquantitative protein estimation,
active urine sediment in the form of three red
blood cells per high power field and/or renal
biopsy results consistent with lupus nephritis. All
patients were positive for antinuclear antibody and
none had clinical or serologic evidence of Sjogren’s
syndrome.
Assessment of lupus disease activity was done by
calculating the “weighted” index for nine organ
systems’ involvement utilizing the Systemic Lupus
Erythematosus Disease Activity Index (SLEDAI) as
described by Bombardier et al [18]. This index gives
eight points for involvement of the central nervous and
vascular systems; four points for the renal and
musculoskeletal systems; two points for serosal, dermal
and immunologic systems; and one point for
constitutional and hematologic symptoms. Patients with
scores of 10 or less were considered to have inactive
disease, while patients with scores greater than 10 were
considered to have active disease. None of the patients
had exacerbations of lupus activity during the preceding
3-month period and all of them were considered to have
stable disease. Patients were excluded if their plasma
creatinine level was more than 3 mg/dL and if they had
received cyclophosphamide pulse therapy or diuretics,
or had urinary tract infection within the 2-week period
preceding the day of evaluation.
Ten age- and sex-matched healthy volunteers who
had no evidence of lupus nephritis served as controls.
Informed consent was obtained from all the patients
and healthy volunteers. The study was approved by the
hospital ethics committee.
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Standard laboratory assessments
Before performing the study, routine blood counts and
blood chemistries were done on all patients. A detailed
drug history including the dosages and durations of
steroids and cytotoxic drugs was obtained. All patients
were on a regular follow-up schedule at our renal clinic.
The following procedures were performed on all
patients: urine microscopic examination, tests for
reducing substances and culture of a freshly voided
sample; 24-hour collection of urine for estimation of
creatinine, amino acids, total proteins, ` 2+g, and urinary
enzymes including alkaline phosphatase (ALP),
leucine aminopeptidase (LAP) and gamma-
glutamyltransferase (GGT); serum creatinine and ` 2+g;
and urinary acidification testing.
Assessment of proximal tubular function
Beta-2-microglobulin excretion
Beta-2-microglobulin was estimated quantitatively
using a particle enhanced turbidimetric assay after 2
days of sodium bicarbonate administration to alkalinize
the urine [19]. The endogenous creatinine clearance
(Ccr) and FE-`2+g were calculated using standard
formulae.
Urinary enzyme excretion
ALP was estimated as described by Kind and King [20].
Enzymatic hydrolysis of disodium phenyl phosphate,
under defined conditions of time, temperature and pH,
releases phenol, which was assessed colorimetrically.
LAP was estimated by the method described by
Goldbarg and Rutenberg [21]. The underlying principle
is that enzymatic hydrolysis of the substrate L-leucine-
p-nitroanilide liberates p-nitroaniline, which is
diazotized with sodium nitrite, converting it to an azo
dye that is a blue colored complex, with maximum
absorbance at 540 nm. GGT was estimated by detection
of p-nitroaniline liberated during enzymatic transfer of
gamma-glutamyl groups from gamma-glutamyl-p-
nitroanilide to glycylglycine, as described by Naftalin
et al [22].
Urinary amino acids and glycosuria were measured
using standard methods.
Assessment of distal tubular function
The short ammonium chloride test, as described by
Wrong and Davies [23], was used to assess urinary
acidification. After a light breakfast in the morning, each
patient was given 100 mg/kg of ammonium chloride
dissolved in a glass of water and taken over 30 minutes.
Urine samples were collected just before, and at 2, 4
and 6 hours after ammonium chloride administration.
A venous sample for blood bicarbonate testing was
taken before the ammonium chloride was administered
and at 4 hours after loading. Throughout the test, each
patient was advised to drink 100–150 mL water/hr. The
urine samples were analyzed for pH. Titratable acidity
and ammonium excretion were estimated by standard
methods [10]. Tests of acidification and 24-hour urinary
tubular enzyme excretion tests were also performed on
the 10 control subjects.
Renal histology
Percutaneous renal biopsies were performed on 12
patients only as the others did not give consent for the
procedure. The biopsies were analyzed in accordance
with World Health Organization criteria for lupus
nephritis [24], and activity and chronicity indices were
calculated as suggested by Austin et al [25]. The activity
index was graded on a scale of 0 to 24 by calculating
the sum of individual scores (0 to 3+) for histologic
parameters, including endocapillary proliferation,
neutrophil infiltration, wire-loop deposits, fibrinoid
necrosis ,  cel lular  crescents  and inters t i t ia l
inflammation. Scores for fibrinoid necrosis and cellular
crescents were multiplied by two. Similarly, the index
of chronicity was graded on a scale of 0 to 12, with 0 to
3+ scoring of histologic features,  including
glomerulosclerosis, fibrous crescents, tubular atrophy
and interstitial fibrosis.
An interstitial index was also calculated by the
method of O’Dell et al [2], allowing quantification of
the degree of tubular and interstitial damage. The
interstitial index equaled the sum of the scores achieved
for the degree of mononuclear cell infiltrates, interstitial
fibrosis and tubular atrophy. The renal biopsy
specimens were blindly reviewed by two independent
observers and the activity, chronicity and interstitial
indices reported were the mean scores obtained by the
two observers.
Statistical analyses
Statistical analyses were performed using the Student’s
t test. All results are expressed as mean ( standard
deviation (SD). A p value of less than 0.05 was
considered significant.
RESULTS
Twenty patients were studied. The mean (( SD) age
was 34.4 ( 15.3 years (range, 9–60 yr). There were 17
females (85%) and three males. The duration of illness
ranged from 0.25 to 9 years, with a mean of 2.9 ( 2.2
years. Disease activity, as calculated using SLEDAI
[18] criteria, is shown in Table 1. Seven patients had a
SLEDAI index of 10 or less, whereas the remaining
patients had indices varying between 11 and 25 (mean,
13.4 ( 4.4), indicating active disease. Eleven patients
were on prednisolone and/or azathioprine for more than
3 months, and one had received intravenous
cyclophosphamide 4 weeks before the evaluation. Six
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Table 1. Presenting laboratory features and tests of renal tubular function in lupus nephritis patients.
Patient SLEDAI GFR 24-hr Serum Minimum Baseline Peak Serum FE-`2+g ALP LAP GGT
mL/min  urinary Cr urinary TA TA `2+g (%) (+mol/L/ (+mol/L/ (+mol/L/
protein (g) mg/dL pH (mmol/L) (mmol/L) (mg/L) min) min) min)
1 16 52.08 1.0 0.9 4.7 16 24 7.00 2.30 3.54 3.18 46.02
2 10 77.16 1.1 0.9 5.8   4 8 6.46 0.99 5.12 3.28 162.63
3 10 69.44 1.4 0.9 4.8 20 28 4.75 1.50 7.79 1.79 85.44
4 12 57.80 3.9 1.2 6.6 14 14 6.60 1.70 3.28 2.25 83.88
5 11 83.33 1.8 1.0 5.1 44 74 6.20 1.08 1.46 11.05 18.72
6 10 52.08 6.0 1.2 5.0 32 64 3.99 1.08 2.00 1.55 24.05
7 13 69.44 1.2 1.0 4.7 32 70 3.99 1.81 5.11 6.19 48.90
8 9 52.08 0.6 1.2 5.1 24 50 7.33 2.09 16.68 8.88 53.64
9 20 69.44 0.6 1.0 5.0 28 60 7.35 1.68 14.33 4.92 73.15
10 14 62.50 0.8 1.0 4.7 30 36 3.20 2.25 10.00 7.10 80.79
11 8 69.44 0.5 0.6 5.7 46 46 7.47 0.78 4.44 2.31 12.48
12 25 46.29 0.6 1.2 4.8 20 40 3.80 2.21 2.97 3.96 44.85
13 15 46.29 0.5 0.9 4.5 24 44 4.27 4.80 3.68 4.11 49.15
14 14 24.50 1.2 1.7 5.1 64 80 3.74 1.51 5.99 1.95 48.38
15 12 104.25 0.5 0.8 5.1 16 32 4.75 0.89 4.03 16.16 99.10
16 18 54.12 7.6 0.9 6.1 20 24 4.90 1.67 5.23 4.12 55.67
17 10 69.44 2.1 0.8 4.7 24 36 4.50 1.49 14.78 3.85 73.08
18 11 31.99 0.6 1.7 4.8 35 40 5.80 0.34 18.11 13.19 60.11
19 20 28.0 1.2 2.0 6.0 30 50 6.60 1.28 3.23 4.28 27.50
20 10 52.0 0.6 1.2  ND ND ND 5.80 0.75 5.83 4.08 40.96
Mean ( 13.4 (  58.9 ( 1.69 ( 1.10 ( 5.17 ( 27.53 ( 43.26 ( 5.48 ( 1.61 ( 6.88 ( 5.41 ( 59.43 (
SD 4.4 19.1 1.93 0.34 0.58 13.46 20.10 1.39 0.92 5.08 3.99 33.70
Controls
Mean ( 96.3 ( 4.65 ( 35.20 ( 45.80 ( 1.54 ( 0.09 ( 3.04 ( 16.12 ( 33.41 (
SD 12.1 0.26 20.49 23.20 0.45 0.03 1.19 3.86 19.74
p < 0.01* < 0.05 < 0.05 < 0.05 > 0.05 < 0.05 < 0.05 < 0.05 < 0.0005 < 0.05
*SLEDAI versus tubular dysfunction. SLEDAI = Systemic Lupus Erythematosus Disease Activity Index [18]; GFR = glomerular filtration
rate; Cr = creatinine; TA = titratable acidity; `2+g = beta-2 microglobulin; FE = fractional excretion; ALP = alkaline phosphatase;
LAP = leucine aminopeptidase; GGT = gamma-glutamyltransferase.
patients had hypertension that was adequately
controlled with drugs (which included enalapril,
nifedipine and atenolol). At the time of study, none of
them were on diuretics.
Urine culture results were negative in all cases. No
patient had detectable reducing substances in the urine.
The renal parameters, including tests of proximal
and distal tubular function, are shown in Table 1.
The mean glomerular filtration rate (GFR) was 58.9 (
19.1 mL/min (control GFR, 96.3 ( 12.1 mL/min). The
24-hour urine protein excretion ranged from 0.5–7.6 g.
Serum `2+g levels were increased in all patients and
ranged from 3.2–7.47 mg/L (control, 0.96–2.08 mg/L).
One patient who had a GFR of 104.25 mL/min also
had elevated `2+g levels. Urinary `2+g levels were
5.37 ( 2.12 mg/L (control, 1.8 ( 0.4 mg/L), and
FE-`2+g ranged from 0.34–4.8%. There was no
correlation between FE-`2+g and GFR or 24-hour
urinary protein excretion, and the mean values did not
significantly differ whether patients were on steroids
or not (1.59 vs 1.61 g/day; p > 0.05).
There were significant variations in 24-hour urinary
enzyme levels (Table 1). The mean values in the
control group were 3.04 ( 1.19 +mol/L/min for ALP,
16.12 ( 3.86 +mol/L/min for LAP, and 33.41 (
19.74 +mol/L/min for GGT. ALP levels among patients
ranged from 1.46–18.11 +mol/L/min. For ALP
excretion, 65% of patients exceeded the 95th percen-
tile of control values. LAP levels ranged from
1.55–16.16 +mol/L/min. Only 20% of patients had
values above the 95th percentile. GGT levels ranged
from 12.48–162.63 +mol/L/min, and 50% of patients
exceeded the 95th percentile. The mean levels for ALP
and GGT in patients were significantly higher
(p < 0.05), while LAP levels were significantly lower
(p < 0.0005). There was no correlation between the
urinary levels of tubular enzymes, ALP and LAP, and
GFR or proteinuria. However, the levels of GGT
K.L. Gupta, et al
94 Hong Kong J Nephrol • October 2003 • Vol 5 • No 2
negatively correlated with GFR. Steroid treatment did
not influence enzyme levels.
Baseline blood gas analysis showed pH and
bicarbonate to be within the normal range in all patients
except one, who had a compensatory metabolic acidosis
with a urine pH of over 5.3. Thus, an acid load test was
done in 19 patients only. The minimum urinary pH
achieved was higher in the patient group than in the
control group (p < 0.05) (Figure). Similarly, patients
with lupus had a low excretion of titratable acidity in
the basal state (p < 0.05), while the excretion after acid
loading and ammonium excretion before and after acid
loading were similar between the two groups. The
24-hour urinary amino acids ranged from 81.6–
315 mg/day and were within the normal range.
The severity of disease activity, as calculated using
SLEDAI criteria (Table 1), was significantly correlated
with all the parameters of renal function studied in the
lupus patients.
Correlations with renal histology
Renal biopsy lesions, categorized according to the
modified WHO classification system, showed six
patients with class IV disease and three patients each
with class III and V disease (Table 2). The activity index
(range, 2–8; mean 4.9 ( 2.3) was significantly correlated
with the degree of proteinuria, titratable acidity (both
basal and peak), FE-`2+g and urinary GGT (p < 0.01),
whereas the chronicity index (range, 1–7; mean, 3.8 (
2.2) significantly influenced only titratable acidity and
GGT (p < 0.05). On the other hand, severity of tubulo-
interstitial involvement (interstitial index, range, 1–7;
Figure. The means ( (SDs) of: (A) minimum urinary pH; (B) titratable acidity (TA); and (C) NH4+ excretion, at 0, 2, 4 and 6 hours after
ammonium chloride loading. ■ = lupus nephritis; ▲ = control.
Table 2. Renal biopsy findings and activity, chronicity and interstitial scores.
Case no. Renal biopsy finding WHO Class Activity index Chronicity index Interstitial index
1 Membranous V 2 4 3
2 Membranous V 2 4 3
3 Focal proliferative III 5 3 4
4 Diffuse proliferative IV 8 7 7
7 Focal proliferative III 6 1 1
9 Diffuse proliferative IV 6 5 4
11 Diffuse proliferative IV 8 1 5
14 Diffuse proliferative IV 4 4 2
16 Diffuse proliferative IV 8 1 3
17 Membranous V 2 1 2
18 Focal proliferative III 4 7 4
19 Diffuse proliferative IV 4 7 4
Mean index 4.9 ( 2.3 3.8 ( 2.2 3.5 ( 1.6
WHO = World Health Organization.
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mean, 3.5 ( 1.6) influenced all aspects of tubular
function tested to a considerable extent (p < 0.001),
including urinary enzymes, except for LAP.
DISCUSSION
In this prospective study on stable lupus nephritis
patients, we demonstrated a high prevalence of renal
tubular dysfunction. Various studies that had addressed
this issue in the past did not consider dysfunction
involving the different segments of the renal tubules
and had tested only for selective components of tubular
function [7,9–11,14]. Ours is the first study that
addresses the various aspects of tubular function in a
cohort of stable lupus nephritis patients. We specifically
chose patients who did not have any exacerbation of
their disease to find the prevalence and nature of tubular
defects during an apparently quiescent period.
Tubulo-interstitial changes in lupus nephritis are
usually secondary to glomerular damage or
hypertension, or are a direct consequence of extra
glomerular immune injury [5]. The functional
disturbances related to tubular damage are more
frequent, as seen in our study. We found significant
correlation between the calculated interstitial index and
most of the renal functions tested, except for urinary
LAP. On the other hand, some authors have failed to
show correlation with the extent of biopsy changes [9].
We used `2+g, urine enzymes including ALP, LAP
and GGT, and distal acidification testing as indices of
various components of tubular dysfunction. All our
patients had elevated FE and serum `2+g levels (Table
1). In a typical case of tubular proteinuria, albumin
constitutes only about 20% of the total protein, and
detection of low molecular weight proteins such as ` 2+g
is very useful. FE-`2+g has been used to diagnose
tubular dysfunction in the presence of glomerulopathy
[26]. Elevated serum `2+g and FE-`2+g were found by
ter Borg et al [9] in all eight patients studied during
exacerbation of lupus activity. The rise in FE-`2+g
coincided with a fall in GFR. Normal renal glomerular
and tubular protein handling were shown by Parving et
al by measuring the urine albumin and `2+g excretion
rate using radioimmunoassays in 14 SLE patients
without clinical proteinuria [27], thus indicating their
lack of association, as observed in our study.
Yeung et al found FE-`2+g exceeding 2 SDs from
the mean in 14 of 20 patients and in nine of 20 in the
control group [6]; this occurred with serum `2+g levels
of less than 4.5 mg/L. As observed in our study, these
authors did not find any correlation between use of
prednisolone, 24-hour urinary protein excretion, Ccr,
serum `2+g levels and FE-`2+g, and attributed this
raised FE to early proximal tubular dysfunction. Except
for one, all of our patients had reduced GFRs. Though
serum `2+g levels were elevated, raised FE-`2+g in the
presence of reduced GFR points to proximal tubular
dysfunction. Moreover, 35% of our patients had serum
`2+g levels of less than 4.5 mg/L and still had elevated
FE-`2+g levels. Although the threshold serum level of
less than 4.5 mg/L is debatable, we concur with Yeung
et al [6] and view this as clear evidence of proximal
tubular dysfunction. Furthermore, we discount the
possibili ty of reduced tubular function as a
compensatory response to reduced GFR.
Urinary excretion of `2+g, retinol binding protein
(RBP) and _1-microglobulin are currently the indicators
of choice for detecting proximal tubular dysfunction
[28]. Similarly, Sesso et al found elevated urinary RBP
levels in 17 of 22 patients with active lupus nephritis,
six of 18 with probable active nephritis, one of nine
with stable renal disease, and one of 21 without apparent
renal disease [29]. They could not attribute it completely
to the effects of increased total proteinuria or reduced
GFR. However, we did not use RBP to test for proximal
tubular dysfunction in our patients because of the lack
of this facility during our study.
Various studies recommend the estimation of urinary
enzymes as useful markers for the detection of small
changes in proximal tubular function [30]. We chose
to estimate the activity of urinary enzymes in 24-hour
urine samples to negate the element of diurnal variation
in excretion, as suggested by Jung [30]. The reference
limits we used were the enzyme activities in the urine
of 10 apparently healthy volunteer controls. When
values greater than 2 SD of the control group mean
were taken as abnormal, we found evidence of tubular
dysfunction in as many as 65% of our patients when
measuring ALP and 50% of patients when measuring
GGT. Delektorskaya et al found elevated urinary levels
of GGT, ALP and N-acetyl glucosaminidase in 31
patients without any clinical or laboratory evidence of
active lupus nephritis [15]. We also did not find any
correlation between enzymuria and 24-hour total
protein excretion, or Ccr. Rovensky et al found
abnormal urinary lactate dehydrogenase, LAP and
alanine aminopeptidase to be useful markers of
proximal tubular dysfunction in SLE [16]. Fourteen of
their 54 patients showed elevated enzymes preceding
the development of clinical signs of nephropathy, while
14 who did not have any evidence of nephropathy had
normal enzyme levels. The enzyme levels normalized
in all nine patients who had a favorable response to
immunosuppression therapy. The urinary LAP levels
in our patients were significantly lower when compared
with controls. We are unable to explain this finding,
which is contrary to that described by others.
None of our patients had glycosuria or elevated 24-
hour urinary excretion of amino acids, suggesting an
absence of generalized proximal tubular dysfunction.
Twenty percent of our patients were unable to
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acidify their urine below a pH of 5.3 following a short
NH4Cl loading test. There are a number of isolated case
reports describing distal renal tubular acidosis (RTA)
in both adults and children with lupus nephritis [10,11,
31]. A higher incidence of acidification defects in lupus
nephritis was reported by Kozeny et al, who found distal
RTA in 18 out of 30 (60%) patients [10], while Feng
found it in 62% of 37 patients with lupus nephritis [14].
On the other hand, Yeung et al found an abnormality in
distal acidification in only five of 20 patients, with no
correlation to underlying renal histology [6]. We found
significant correlation between the severity of histologic
renal presentation and acidification defects. We do not
have any explanation for this discrepancy.
Tubulo-interstitial involvement is quite common in
patients with lupus nephritis. The occurrence of
extraglomerular immune complex deposits varies from
12.5% to 67% in different studies [8]. Tubulo-interstitial
involvement correlates better with impaired GFR than
the degree of glomerular damage in a number of
glomerular diseases and is probably true for lupus
nephritis as well. We attempted to evaluate a number
of tubular functions in a group of stable lupus nephritis
patients. We found a high prevalence of tubular
functional abnormalities in our patients, particularly
increased excretion of `2+g and urinary enzymes such
as ALP and GGT. Thus, tubular functional abnor-
malities may suggest an early diagnosis of lupus
nephritis and help to determine patient prognosis. More
studies are needed to determine the extent to which early
detection of tubular dysfunction may aid in the better
management of patients with diffuse proliferative lupus
nephritis.
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